Core Insights - Financial stress in Canada increased in Q4 2025, but at a slower rate compared to previous years, with older consumers showing resilience while younger consumers and those in Ontario and Western provinces exhibited financial weakening [1] Consumer Debt Trends - Total consumer debt reached $2.65 trillion in Q4 2025, marking a 3.13% year-over-year increase, driven by a $50.26 billion rise in mortgage balances and a 4.50% increase in non-mortgage debt [2] - Delinquency rates for non-mortgage debt rose, with 90+ day delinquency increasing from 1.64% to 1.73%, a year-over-year increase of 5.43% [2] Age Group Analysis - Consumers aged 26 to 35 experienced the highest credit stress, with a delinquency rate of 2.55% and an 8.39% year-over-year decline in credit health [3] Regional Divergence - A "two Canadas" scenario emerged, with Ontario experiencing the fastest growth in non-mortgage delinquency at 10.31% compared to Q4 2024, while regions with better housing affordability like Prince Edward Island and Nova Scotia saw decreases in delinquency rates [4] Credit Card Spending - Credit card spending during the 2025 holiday season decreased by 0.7% year-over-year to $2,297, with younger consumers (aged 26-35) reducing their holiday spending by 2.0% [5] - Despite reduced spending, credit card balances reached a historic $131 billion, an increase of 4.04% [5] Borrowing Power and Credit Access - Lenders tightened access to credit for riskier borrowers, with non-mortgage debt for subprime consumers remaining stagnant, while super prime consumers saw a 6.1% increase in average non-mortgage debt to $20,818 [6] Mortgage Market Dynamics - Total mortgage debt reached $1.95 trillion in Q4 2025, a 2.6% year-over-year increase, with mortgage renewals dominating the market [7] - Average new loan amounts increased by 4.1% to $363,778, with first-time homebuyers facing an average new loan size of $441,301, up 5% [8] Interest Rate Impact - The Bank of Canada's 2.25% policy rate provided some relief, but housing affordability remained strained, particularly in high-priced regions like Ontario and British Columbia [8] - Rising missed payments on higher-value mortgages in Ontario indicated that post-renewal payment levels were too high for some consumers [9]

Core Points - The Annual General Meeting of Festi hf. is scheduled for March 5, 2026, at 10:00 a.m. at the company's headquarters in Kópavogur [1] - The agenda and proposals published on February 10, 2026, remain unchanged, and no additional proposals were received from shareholders for the Nomination Committee [1] - The deadline for submitting candidacies for the Board of Directors has passed, and the Board will be elected unopposed at the Annual General Meeting [2] Board of Directors Candidates - The following individuals have submitted candidacies for the Board of Directors: Edda Blumenstein, Guðjón Auðunsson, Guðjón Reynisson, Hjörleifur Pálsson, and Sigurlína Ingvarsdóttir [4] - The Board of Directors will consist of five members elected for a one-year term at the Annual General Meeting [2] Meeting Information - Meeting materials and additional information regarding the Annual General Meeting can be found on the company's website [3] - For further inquiries, contact Ásta S. Fjeldsted, CEO of Festi hf. [3]

Core Viewpoint - Amoéba is in the final phase of obtaining marketing authorization for its biocontrol product AXPERA in France, with the assessment process led by ANSES, the French Agency for Food, Environmental and Occupational Health & Safety [1][9]. Group 1: Marketing Authorization Process - The marketing authorization application for AXPERA was submitted in March 2025, and France is acting as the rapporteur Member State for the assessment [2]. - The final stage of the assessment includes a comment phase on the draft Registration Report, which is open until March 6, 2026, after which the official marketing authorization will be published [3]. - Amoéba believes there are no obstacles to the marketing authorization, as all requested uses have been deemed acceptable and the product's safety profile confirmed [4]. Group 2: Derogatory Authorizations - Agricultural sectors in France and Italy are seeking exceptional marketing authorizations for AXPERA to address phytosanitary emergencies, similar to the authorization granted in 2025 for use against downy mildew in vineyards [5]. - A new application for exceptional authorization for large-scale trials in the Netherlands has been submitted, allowing AXPERA to be used on multiple crops [6]. - If granted, these derogatory authorizations would enable AXPERA to be marketed for specific uses regardless of the final timetable for standard marketing authorization [7]. Group 3: Company Overview - Founded in 2010, Amoéba specializes in microbiological risk treatment using patented amoebae technology for plant protection and cosmetics [8]. - The company is the only one authorized to use Willaertia amoeba industrially for biocontrol and cosmetic applications, with a focus on the global biocontrol market [10]. - The active substance of AXPERA has been approved in the United States since 2022, and product registration is expected in France in 2026 [11].

NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- ESW announced today the continued growth of ExcelHelp.com, its national Microsoft training and automation brand focused on delivering instructor-led Excel, Copilot, and AI training & consulting for modern organizations. As companies invest heavily in Microsoft 365 and AI tools, many struggle to ensure employees are using them effectively. ExcelHelp.com helps close that gap through structured, hands-on group training designed to improve real productivity across de ...

Core Insights - The fleet utilization for January 2026 was reported at 100%, indicating strong operational performance across the company's vessels [1] - Safe Caledonia achieved 100% commercial uptime at the Captain Field in the UK, with a new Letter of Intent (LoI) from Ithaca Energy for a 6-month firm contract starting in Q2 2027 [2][3] - The company aims to capture strong market demand to grow its backlog at higher day rates while focusing on operational efficiencies and cost reductions for revenue growth and long-term value creation [4] Vessel Performance - Safe Eurus, Safe Notos, and Safe Zephyrus operated at near 100% commercial uptime in Brazil during January 2026 [1] - Safe Boreas is currently receiving full day rates and is awaiting the start of a 15-month firm period, expected to commence in Q1 2026 [2] Strategic Partnerships - The cooperation with Ithaca Energy has been positive since the contract began in August 2024, with Safe Caledonia providing high-quality accommodation support in the North Sea [3] - The company is exploring opportunities to bridge the gap until the start of the 2027 contract linked to the LoI, as well as potential contracts for 2028 and beyond [3] Company Overview - Prosafe is a leading owner and operator of semi-submersible accommodation vessels, listed on the Oslo Stock Exchange under the ticker code PRS [5]

24 February 2026 - Fleet utilisation for January 2026 was 100%. In Brazil, Safe Eurus, Safe Notos, and Safe Zephyrus continued to operate at full capacity in January, delivering near 100 % commercial uptime. Safe Caledonia maintained 100% commercial uptime at the Captain Field in the UK. The vessel ended the contract for Ithaca Energy on 22 February 2026 following the exercise of all option periods. The vessel has a Letter of Intent (LoI) from Ithaca Energy for 6 months firm and 3 months of options from t ...

Core Insights - BIO-key International, Inc. has entered into a multi-year agreement with Sociedade Interbancária de Moçambique (SIMO) to enhance identity and access security in Mozambique's financial ecosystem [1][3] - The partnership aims to modernize SIMO's identity security infrastructure, aligning with international best practices and supporting the digital transformation of Mozambique's financial sector [3][4] Group 1: Agreement Details - The agreement involves the integration of BIO-key's PortalGuard® IAM platform, PIN:You™ tokenless authentication, and Single Sign-On (SSO) capabilities into SIMO's environment [2] - This collaboration builds on a previous IAM deployment in May 2025 for a major National Bank in Mozambique [1] Group 2: Strategic Importance - SIMO plays a crucial role in Mozambique's banking system by providing interoperability, clearing, and settlement services through the national electronic payments network, SIMOrede [4][6] - As digital banking adoption increases in Mozambique, the need for robust identity security is essential for maintaining trust and regulatory compliance [4] Group 3: Stakeholder Perspectives - Juna Chiloveque, SIMO's CISO, emphasized the importance of identity security for ensuring trust and operational resilience in payment services [5] - Miguel Guerreiro from RunLevel highlighted the commitment to strengthening digital trust across Africa's financial ecosystems through this partnership [5] - Alex Rocha from BIO-key noted that the collaboration marks a significant step in supporting secure digital banking infrastructure in Mozambique [5]

Core Viewpoint - Aspo Plc has reported a transaction involving Miska Kuusela, a senior manager, who received a share-based incentive on February 20, 2026, with a total volume of 2,120 shares at a unit price of 0 EUR [1]. Group 1: Transaction Details - The transaction was categorized as an initial notification and was conducted outside a trading venue [1]. - The aggregated transaction details indicate a volume of 2,120 shares with a volume-weighted average price of 0 EUR [1]. - The transaction is part of Aspo Plc's incentive program for its management [1].

Key Information - The exempt principal trader involved is Investec Bank plc, which is connected to CAB Payments Holdings Plc as a Joint Broker [1] - The dealing date was 23 February 2026 [1] Dealings by the Exempt Principal Trader - Purchases of ordinary shares totaled 44,885 units at a highest price of 84.0129 and a lowest price of 84.0129 [3] - Sales of ordinary shares also totaled 44,885 units, with a highest price of 85 and a lowest price of 82 [3] Other Information - There are no indemnity or other dealing arrangements related to the relevant securities [9] - There are no agreements, arrangements, or understandings regarding options or derivatives related to voting rights or future acquisitions [10]

Core Viewpoint - Wolters Kluwer has successfully completed a share buyback program, repurchasing a total of 1,318,031 shares for €99.9 million in 2026 to date, with an average share price of €75.79 [2][4]. Share Buyback Details - From February 19 to February 23, 2026, the company repurchased 130,851 ordinary shares for €8.1 million at an average price of €61.90 [1]. - The previously disclosed agreement to repurchase €200 million in shares has been fulfilled, indicating strong capital management [2]. Company Overview - Wolters Kluwer reported annual revenues of €5.9 billion for 2024 and operates in over 180 countries with approximately 21,900 employees [4]. - The company is a leader in professional information solutions, software, and services across various sectors including healthcare, tax, accounting, and legal [3].